US Large Cap Pharmaceuticals: Mid-Year State Of Play July 2025 | Asad Haider | Goldman, Sachs & Co. | asad.haider@gs.com | 1-212-902-0691 | | --- | --- | --- | --- | | Nick Jennings | Goldman, Sachs & Co. | nick.jennings@gs.com 1-917-277-2797 | | | Jeff Su | Goldman, Sachs & Co. | jeff.su@gs.com | 1-212-285-9184 | Goldman Sachs does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that the firm may have a conflict of interest that could affect t ...